F. Philippart, Prise en charge des infections des voies respiratoires basses de l'immunocompétent. Partie concernant les définitions, l'épidémiologie et les éléments du diagnostic. Médecine et Maladies Infectieuses, pp.11-12784, 2006.

M. Woodhead, J. Macfarlane, J. Mccracken, D. Rose, and R. Finch, PROSPECTIVE STUDY OF THE AETIOLOGY AND OUTCOME OF PNEUMONIA IN THE COMMUNITY, The Lancet, vol.329, issue.8534, pp.671-675, 1987.
DOI : 10.1016/S0140-6736(87)90430-2

J. Leuppi, T. Dieterle, G. Koch, M. B. Tamm, M. Perruchoud et al., Diagnostic value of lung auscultation in an emergency room setting, Swiss Med Wkly, vol.135, pp.35-36520, 2005.

L. Mandell, R. Wunderink, A. Anzueto, J. Bartlett, G. Campbell et al., Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults, Clinical Infectious Diseases, vol.44, issue.Supplement 2, pp.27-72, 2007.
DOI : 10.1086/511159

G. Nair and M. Niederman, Community-Acquired Pneumonia: An Unfinished Battle, Medical Clinics of North America, vol.95, issue.6, pp.1143-61, 2011.
DOI : 10.1016/j.mcna.2011.08.007

D. Angus, T. Marrie, D. Obrosky, G. Clermont, T. Dremsizov et al., Severe Community-acquired Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.166, issue.5, pp.717-740, 2002.
DOI : 10.1164/rccm.2102084

M. Falguera, J. Carratalà, S. Bielsa, C. García-vidal, A. Ruiz-gonzález et al., Predictive factors, microbiology and outcome of patients with parapneumonic effusion, European Respiratory Journal, vol.38, issue.5, pp.1173-1182, 2011.
DOI : 10.1183/09031936.00000211

C. Strange and S. Sahn, The definitions and epidemiology of pleural space infection, Semin Respir Infect, vol.14, issue.1, pp.3-8, 1999.

T. Chonmaitree and K. Powell, Parapneumonic Pleural Effusion and Empyema in Children: Review of a 19-Year Experience, 1962-1980, Clinical Pediatrics, vol.22, issue.6, pp.414-423, 1983.
DOI : 10.1177/000992288302200603

C. Grijalva, Y. Zhu, J. Nuorti, and M. Griffin, Emergence of parapneumonic empyema in the USA, Thorax, vol.66, issue.8, pp.663-671, 2011.
DOI : 10.1136/thx.2010.156406

C. Byington, L. Spencer, T. Johnson, A. Pavia, D. Allen et al., An Epidemiological Investigation of a Sustained High Rate of Pediatric Parapneumonic Empyema: Risk Factors and Microbiological Associations, Clinical Infectious Diseases, vol.34, issue.4, pp.434-474, 2002.
DOI : 10.1086/338460

G. Voiriot, S. Dury, A. Parrot, C. Mayaud, and M. Fartoukh, Nonsteroidal Antiinflammatory Drugs May Affect the Presentation and Course of Community-Acquired Pneumonia, Chest, vol.139, issue.2, pp.387-94, 2011.
DOI : 10.1378/chest.09-3102

D. Aujesky and M. Fine, The Pneumonia Severity Index: A Decade after the Initial Derivation and Validation, Clinical Infectious Diseases, vol.47, issue.S3, pp.133-139, 2008.
DOI : 10.1086/591394

A. Capelastegui, P. España, J. Quintana, I. Areitio, I. Gorordo et al., Validation of a predictive rule for the management of community-acquired pneumonia, European Respiratory Journal, vol.27, issue.1, pp.151-158, 2006.
DOI : 10.1183/09031936.06.00062505

Y. Loke, C. Kwok, A. Niruban, and P. Myint, Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis, Thorax, vol.65, issue.10, pp.884-90, 2010.
DOI : 10.1136/thx.2009.134072

M. Fine, L. Hough, A. Medsger, Y. Li, E. Ricci et al., The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study, Archives of Internal Medicine, vol.157, issue.1, pp.36-44, 1997.
DOI : 10.1001/archinte.157.1.36

J. Chalmers, A. Singanayagam, M. Murray, C. Scally, A. Fawzi et al., Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia, Thorax, vol.64, issue.7, pp.592-599, 2009.
DOI : 10.1136/thx.2008.105080

R. Ahmed, T. Marrie, and J. Huang, Thoracic Empyema in Patients with Community-Acquired Pneumonia, The American Journal of Medicine, vol.119, issue.10, pp.877-83, 2006.
DOI : 10.1016/j.amjmed.2006.03.042

R. Menendez and A. Torres, Treatment failure in community-acquired pneumonia. Chest, pp.1348-55, 2007.

S. Chouaib and J. Bertoglio, Prostaglandins E as modulators of the immune response, Lymphokine Res, vol.7, issue.3, pp.237-282, 1988.

M. Hussain, A. Javeed, M. Ashraf, Y. Zhao, M. Mukhtar et al., Aspirin and immune system, International Immunopharmacology, vol.12, issue.1, pp.10-20, 2012.
DOI : 10.1016/j.intimp.2011.11.021

D. Aronoff, C. Canetti, and M. Peters-golden, Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP, The Journal of Immunology, vol.173, issue.1, pp.559-65, 2004.
DOI : 10.4049/jimmunol.173.1.559

C. Raherison, P. Peray, R. Poirier, P. Romand, J. Grignet et al., Management of lower respiratory tract infections by French general practitioners: the AIR II study, European Respiratory Journal, vol.19, issue.2, pp.314-323, 2002.
DOI : 10.1183/09031936.02.00219102

J. Messika, B. Sztrymf, F. Bertrand, T. Billard-pomares, G. Barnaud et al., Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: Younger and more severely affected patients, Journal of Critical Care, vol.29, issue.5, pp.733-741, 2014.
DOI : 10.1016/j.jcrc.2014.05.021

P. François, A. Desrumaux, C. Cans, I. Pin, P. Pavese et al., Prevalence and risk factors of suppurative complications in children with pneumonia, Acta Paediatrica, vol.25, issue.6, 2010.
DOI : 10.1111/j.1651-2227.2010.01734.x

M. Elemraid, M. Thomas, A. Blain, S. Rushton, D. Spencer et al., Risk factors for the development of pleural empyema in children, Pediatric Pulmonology, vol.13, issue.7, pp.721-727
DOI : 10.1002/ppul.23041

S. Leroy, E. Marc, F. Bavoux, J. Tréluyer, D. Gendrel et al., Hospitalization for Severe Bacterial Infections in Children after Exposure to NSAIDs, Clinical Drug Investigation, vol.27, issue.3, pp.179-85, 2010.
DOI : 10.2165/11532890-000000000-00000

C. Souyri, P. Olivier, S. Grolleau, and M. Lapeyre-mestre, Severe necrotizing soft-tissue infections and nonsteroidal anti-inflammatory drugs, Clinical and Experimental Dermatology, vol.135, issue.3, pp.249-55, 2008.
DOI : 10.1016/S0755-4982(04)98821-5

A. Legras, B. Giraudeau, A. Jonville-bera, C. Camus, B. François et al., A multicentre case-control study of nonsteroidal anti-inflammatory drugs as a risk factor for severe sepsis and septic shock, Critical Care, vol.13, issue.2, p.43, 2009.
DOI : 10.1186/cc7766

URL : https://hal.archives-ouvertes.fr/inserm-00533142

J. Demeslay, D. Bonnecaze, G. Vairel, B. Chaput, B. Pessey et al., Possible role of anti-inflammatory drugs in complications of pharyngitis. A retrospective analysis of 163 cases. Eur Ann Otorhinolaryngol Head Neck Dis, pp.299-303, 2014.

D. Aronoff and K. Bloch, Assessing the Relationship Between the Use of Nonsteroidal Antiinflammatory Drugs and Necrotizing Fasciitis Caused by Group A Streptococcus, Medicine, vol.82, issue.4, pp.225-260, 2003.
DOI : 10.1097/01.md.0000085060.63483.bb

D. Zerr, E. Alexander, J. Duchin, L. Koutsky, and C. Rubens, A Case-Control Study of Necrotizing Fasciitis During Primary Varicella, PEDIATRICS, vol.103, issue.4, pp.783-90, 1999.
DOI : 10.1542/peds.103.4.783

A. Rosh and D. Newman, Diagnosing Pneumonia by Medical History and Physical Examination, Annals of Emergency Medicine, vol.46, issue.5, pp.465-472, 2005.
DOI : 10.1016/j.annemergmed.2005.08.011

C. Samain, P. Lévy, J. Boitiaux, M. Gosset-woimant, S. Pham et al., Influence de la prise pr??alable d???anti-inflammatoires non st??ro??diens sur la pr??sentation et l?????volution de pneumonies aigu??s communautaires hospitalis??es, Revue des Maladies Respiratoires, vol.32, pp.2015-2029
DOI : 10.1016/j.rmr.2014.11.039

P. Calverley, J. Anderson, B. Celli, G. Ferguson, C. Jenkins et al., Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease, New England Journal of Medicine, vol.356, issue.8, pp.775-89, 2007.
DOI : 10.1056/NEJMoa063070

J. Sellares, A. López-giraldo, C. Lucena, C. Cilloniz, R. Amaro et al., Influence of Previous Use of Inhaled Corticoids on the Development of Pleural Effusion in Community-acquired Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.187, issue.11, pp.1241-1249, 2013.
DOI : 10.1164/rccm.201209-1732OC

P. Laterre, G. Garber, H. Levy, R. Wunderink, G. Kinasewitz et al., Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study*, Critical Care Medicine, vol.33, issue.5, pp.952-61, 2005.
DOI : 10.1097/01.CCM.0000162381.24074.D7

P. Moine, J. Vercken, S. Chevret, and P. Gajdos, Severe community-acquired pneumococcal pneumonia. The French Study Group of Community-Acquired Pneumonia in ICU. Scand, J. Infect. Dis, vol.27, issue.3, pp.201-207, 1995.